An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline

BACKGROUND: Doxorubicin (DOX)-based chemotherapy for Hodgkin lymphoma (HL) yields excellent disease-free survival, but poses a substantial risk of subsequent left ventricular (LV) dysfunction and heart failure, typically with delayed onset. At the cellular level, this cardiotoxicity includes derange...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarocchi, Matteo, Bauckneht, Matteo, Arboscello, Eleonora, Capitanio, Selene, Marini, Cecilia, Morbelli, Silvia, Miglino, Maurizio, Congiu, Angela Giovanna, Ghigliotti, Giorgio, Balbi, Manrico, Brunelli, Claudio, Sambuceti, Gianmario, Ameri, Pietro, Spallarossa, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202821/
https://www.ncbi.nlm.nih.gov/pubmed/30359253
http://dx.doi.org/10.1186/s12967-018-1670-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202821/
https://www.ncbi.nlm.nih.gov/pubmed/30359253
http://dx.doi.org/10.1186/s12967-018-1670-9

Ejemplares similares